{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T02:39:01Z","timestamp":1792636741520,"version":"4.5.0"},"reference-count":61,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2026,6,28]],"date-time":"2026-06-28T00:00:00Z","timestamp":1782604800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"},{"start":{"date-parts":[[2026,6,28]],"date-time":"2026-06-28T00:00:00Z","timestamp":1782604800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Pediatric Dermatology"],"published-print":{"date-parts":[[2026,7]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:p>Immunomodulatory agents have become a mainstay treatment for various dermatologic conditions within the pediatric population. Increased use of off\u2010label and FDA\u2010approved medications, especially at younger ages, decreases disease burden and mortality. The earlier usage of these immunosuppressants often parallels the pediatric vaccine schedule. Successful treatment of dermatologic conditions while enabling children to mount an adequate immunologic response to preventable diseases necessitates partnering between dermatologists and primary care physicians. Understanding the guidelines will enable dermatologists to better educate patients and engage in shared decision\u2010making. A review of the literature for vaccination guidelines for patients on conventional immune modulating medications (CIMM), tumor necrosis factor alpha inhibitors (TNF\u2010i), various biologic medications, and Janus kinase inhibitors (JAKi) was performed. Inactivated vaccines are generally considered safe, and routine administration, including during active treatment with immunosuppressants, is acceptable. For live attenuated vaccines, including measles\u2013mumps\u2013rubella (MMR) and varicella, consideration to vaccinate 4\u2009weeks prior to initiation of immunosuppressants is generally advised.<\/jats:p>","DOI":"10.1111\/pde.70297","type":"journal-article","created":{"date-parts":[[2026,6,28]],"date-time":"2026-06-28T22:51:27Z","timestamp":1782687087000},"page":"800-809","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["State\u2010of\u2010the\u2010Art Review: Vaccination in Pediatric Dermatology Patients Receiving Immunosuppressive or Immunomodulatory Therapy: A Review"],"prefix":"10.1111","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7113-1153","authenticated-orcid":false,"given":"Cordelia R.","family":"Elaiho","sequence":"first","affiliation":[{"name":"Medical College of Wisconsin  Milwaukee Wisconsin USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaditya","family":"Kumar","sequence":"additional","affiliation":[{"name":"Medical College of Wisconsin  Milwaukee Wisconsin USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0382-4470","authenticated-orcid":false,"given":"Kelly","family":"Barry","sequence":"additional","affiliation":[{"name":"Medical College of Wisconsin  Milwaukee Wisconsin USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1486-139X","authenticated-orcid":false,"given":"Philip","family":"Berce","sequence":"additional","affiliation":[{"name":"Medical College of Wisconsin  Milwaukee Wisconsin USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen R.","family":"Humphrey","sequence":"additional","affiliation":[{"name":"Medical College of Wisconsin  Milwaukee Wisconsin USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,6,28]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/B978-1-4557-0090-5.00019-7"},{"key":"e_1_2_6_3_1","unstructured":"World Health Organization \u201cWhat's in a Vaccine? \u201dWorld Health Organization accessed April 7 2026 https:\/\/www.who.int\/news\u2010room\/feature\u2010stories\/detail\/how\u2010are\u2010vaccines\u2010developed."},{"issue":"6","key":"e_1_2_6_4_1","first-page":"727","article-title":"Anti\u2010TNF Treatment Blocks the Induction of T Cell\u2010Dependent Humoral Responses","volume":"72","author":"Salinas G. F.","year":"2013","journal-title":"Annals of the Rheumatic Diseases"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2022.03.041"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2026.1728845"},{"key":"e_1_2_6_7_1","unstructured":"K. L.WinthropandC. O.Bingham III \u201cImmunizations in Autoimmune Inflammatory Rheumatic Disease in Adults \u201d(2024) accessed June 20 2024 https:\/\/www.uptodate.com\/contents\/immunizations\u2010in\u2010autoimmune\u2010inflammatory\u2010rheumatic\u2010disease\u2010in\u2010adults."},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00431\u2010024\u201005654\u20109"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpn.2021.10.009"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1111\/pde.15876"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1093\/mrcr\/rxaf012"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2021.03.032"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.42386"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41584\u2010023\u201000992\u20108"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2022.3488"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.1111\/ddg.14156"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2020.01.037"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00403\u2010024\u201002827\u20102"},{"key":"e_1_2_6_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2005.07.059"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1191\/0961203305LU2109OA"},{"key":"e_1_2_6_21_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis\u20102022\u2010222574"},{"key":"e_1_2_6_22_1","doi-asserted-by":"publisher","DOI":"10.1542\/9781610025225"},{"key":"e_1_2_6_23_1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cit816"},{"key":"e_1_2_6_24_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/ken436"},{"key":"e_1_2_6_25_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2013.6768"},{"key":"e_1_2_6_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2020.10.028"},{"key":"e_1_2_6_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2015.06.086"},{"key":"e_1_2_6_28_1","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines12010082"},{"key":"e_1_2_6_29_1","doi-asserted-by":"publisher","DOI":"10.1002\/acr.23346"},{"key":"e_1_2_6_30_1","unstructured":"42 Recommendations of the Advisory Committee on Immunization Practices (ACIP) \u201cUse of Vaccines and Immune Globulins in Persons With Altered Immunocompetence \u201d1993."},{"key":"e_1_2_6_31_1","first-page":"1098","article-title":"What's Old Is New Again: Measles","volume":"1098","author":"Naureckas Li C.","year":"2025","journal-title":"Pediatrics"},{"key":"e_1_2_6_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2016.01.027"},{"key":"e_1_2_6_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2016.08.014"},{"key":"e_1_2_6_34_1","doi-asserted-by":"publisher","DOI":"10.1097\/MPG.0000000000001188"},{"key":"e_1_2_6_35_1","doi-asserted-by":"publisher","DOI":"10.1002\/jpn3.70158"},{"key":"e_1_2_6_36_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kez030"},{"key":"e_1_2_6_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2013.08.049"},{"key":"e_1_2_6_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2024.12.011"},{"key":"e_1_2_6_39_1","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.rr6701a1"},{"key":"e_1_2_6_40_1","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2011.295"},{"key":"e_1_2_6_41_1","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.200283"},{"key":"e_1_2_6_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2023.10.072"},{"key":"e_1_2_6_43_1","doi-asserted-by":"publisher","DOI":"10.1093\/ibd\/izaf171"},{"key":"e_1_2_6_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2024.07.007"},{"key":"e_1_2_6_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352\u20104642(23)00136\u20100"},{"key":"e_1_2_6_46_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2021\u2010056021"},{"key":"e_1_2_6_47_1","doi-asserted-by":"publisher","DOI":"10.1128\/cvi.00386\u201012"},{"key":"e_1_2_6_48_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40259\u2010017\u20100249\u2010y"},{"key":"e_1_2_6_49_1","doi-asserted-by":"publisher","DOI":"10.1111\/ajd.14464"},{"key":"e_1_2_6_50_1","doi-asserted-by":"publisher","DOI":"10.1111\/pde.15818"},{"key":"e_1_2_6_51_1","doi-asserted-by":"publisher","DOI":"10.1111\/pde.70033"},{"key":"e_1_2_6_52_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2024.03.029"},{"key":"e_1_2_6_53_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2018.07.048"},{"key":"e_1_2_6_54_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.anai.2024.05.014"},{"key":"e_1_2_6_55_1","doi-asserted-by":"publisher","DOI":"10.1093\/bjd\/ljad268"},{"key":"e_1_2_6_56_1","doi-asserted-by":"publisher","DOI":"10.1093\/bjd\/ljae458"},{"key":"e_1_2_6_57_1","unstructured":"National Institutes of Health \u201cA Study to Assess Immunization Responses in Adult and Adolescent Participants With Moderate\u2010to\u2010Severe Atopic Dermatitis Treated With Nemolizumab (Study No. NCT04365387) \u201daccessed April 20 2025 https:\/\/clinicaltrials.gov\/study\/NCT04365387."},{"key":"e_1_2_6_58_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13555\u2010024\u201001217\u2010w"},{"key":"e_1_2_6_59_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev\u2010immunol\u2010083122\u2010044829"},{"key":"e_1_2_6_60_1","doi-asserted-by":"publisher","DOI":"10.25259\/ijdvl_14_2023"},{"key":"e_1_2_6_61_1","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12144695"},{"key":"e_1_2_6_62_1","doi-asserted-by":"publisher","DOI":"10.3390\/v13122379"}],"container-title":["Pediatric Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/pde.70297","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/pde.70297","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/pde.70297","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T02:00:18Z","timestamp":1792634418000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/pde.70297"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,28]]},"references-count":61,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["10.1111\/pde.70297"],"URL":"https:\/\/doi.org\/10.1111\/pde.70297","archive":["Portico"],"relation":{},"ISSN":["0736-8046","1525-1470"],"issn-type":[{"value":"0736-8046","type":"print"},{"value":"1525-1470","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,28]]},"assertion":[{"value":"2025-12-03","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-06-03","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-06-28","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}